1867 results found.
                    
Burst Biologics Spinal Fusion Study
Burst Biologics received IRB approval for a U.S. prospective clinical study of BioBurst cellular allograft in spinal ...
Company Revenue 2016
For these publicly-traded orthopaedic device companies, Exhibits 1 and 2 present 2016 orthopaedic revenue and growth. Exhibit 1 includes links to company's full-year revenue reporting, as well. ...
First U.S. Surgery with MIS Z-Pedicle Screw System in an Open Procedure
Z-Medical announced completion of the first open procedure to employ the MIS Z-Pedicle Screw system in the
Top 5 Orthopaedic Players Post Revenue Growth
Combined, the top five largest players in orthopaedics posted 2016 revenue of US $28.6BB, up $671.7MM or +2.4% vs. ...
Alphatec Announces $18.9 Million Private Placement
Alphatec Spine entered into a definitive securities purchase agreement to raise ~US $18.9MM in a private placement
First Mont Blanc MIS Procedure in the US
Spineway announced completion of the first minimally invasive surgery in the U.S. using the Mont Blanc MIS
Initial Procedures with Lucent XP Expandable Interbody Implant
Spinal Elements announced successful completion of initial procedures using the Lucent® XP expandable inte...
Sussex Wire Acquires Marox
Sussex Wire, manufacturer of cold formed components for a variety of industries, acquired Marox, a manufacturer of orthopaedic implants and ins...
New Evidence-Based Recommendation for Lateral Interbody Fusion in UK
NuVasive announced updated guidance from the National Industry for Clinical Excellence in the U.K. for late...
Xtant Medical Posts 4Q16 and 2016 Revenue
Xtant Medical posted 2016 revenue of US $90.0MM, +4.0% vs. 2015, with 4Q16 revenue of $24.5MM, +9.9% v...
Implanet Enters Exclusive Distribution Partnerships in Australia and New Zealand
Implanet announced integration of its Jazz Claw device into the Australian Register of Therapeutic Good...
Strategic orthopaedic-related 510(k)s issued in February 2017
Strategic orthopaedic-related 510(k)s issued in February 2017 include: NanoFuse (Amend Surgical*), Arrowhead Mini-Rail Fixator (Arrowhead
First Fibroblast Injection in Trial for Spinal Disc Regeneration
SpinalCyte announced the first injection in a clinical trial of CybroCell fibroblasts for spinal disc reg...
Broader FDA Clearance for Spineology Elite Expandable Interbody Fusion System
Spineology received expanded FDA 510(k) clearance of the Elite Expandable Interbody Fusion system, to include a...
DenerveX System Reimbursement Coding Renewed in Germany
The German reimbursement authority renewed payment coding for 2017 for Medovex's DenerveX™ technology for the treatment of ...
First Implantation of Spine Innovation Expandable Interbody Fusion Cage
Spine Innovation announced first implantations of its Expandable TLIF device.
SeaSpine Reports 4Q16 and 2016 Revenue
SeaSpine announced 2016 revenue of US $128.9MM, -3.2% vs. 2015, with 4Q16 revenue of $32.5MM, -6.5% vs. 4...
K2M Reports 4Q16 and 2016 Revenue
K2M posted 2016 revenue of US $236.6MM, +9.6% vs. 2015, with 4Q16 revenue of $61.8MM, +14.0% vs. 4Q15.
Study Results: Use of CT Imaging in Post-op Assessment of Spine Surgery
Studies found that prevalence of CT imaging following complex spine surgery grew more than 2-fold from 6...
Vertiflex Completes $40 Million Financing Round
Vertiflex will use funds from a US $40MM financing round to support U.S. commercial expansion of the Superion®
Distribution Agreement for BoneScalpel in China
Misonix entered into an exclusive agreement with Weigao Orthopedic for distribution of the BoneScalpel in
Three New Ex-U.S. Distribution Partners for VTI
Vertebral Technologies appointed new distributors in Finland, Germany and Sweden to expand access to InterFuse®...
Vertos Medical mild Procedure Receives Broad Coverage Under Medicare
Vertos Medical received broad U.S. Medicare coverage for mild®, a procedure for the treatment of lumb...
K2M Company Profile
A continuously updated record of K2M's financials and strategic events throughout the year. Revenue reflects ORTHOWORLD estimates.   Financials ($MM)* Quarterly
SeaSpine Company Profile
A continuously updated record of SeaSpine's financials and strategic events throughout the year. Revenue reflects ORTHOWORLD estimates.   Financials ($MM)* Quarterly
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2017 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group